Concerted Activation of ETS Protein ER81 by p160 Coactivators, the Acetyltransferase p300 and the Receptor Tyrosine Kinase HER2/Neu
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Activator of thyroid and retinoic acid receptor (ACTR) is overexpressed in approximately 60% of primary human breast tumors and belongs to the p160 steroid receptor coactivator family. In this study, we identified a novel interaction partner of ACTR, the ETS transcription factor ER81 that is also heavily implicated in mammary tumor formation. ACTR and related p160 family members (steroid receptor coactivator-1 and glucocorticoid receptor-interacting protein-1 (GRIP-1)) augment ER81-mediated transcription. Although ACTR and GRIP-1 can acetylate ER81, this posttranslational modification of ER81 is not required for its stimulation by ACTR or GRIP-1. In addition, ACTR collaborates with the p300 coactivator, a joint interaction partner of ACTR and ER81, to stimulate ER81 function and the ability of p300 to acetylate ER81 is indispensable for this collaboration. Furthermore, the receptor tyrosine kinase HER2/Neu, an oncoprotein particularly found overexpressed in breast tumors, cooperates with both ACTR and p300 to stimulate ER81-mediated transcription. Thus, oncogenic HER2/Neu and ACTR may synergize to orchestrate mammary tumorigenesis through the dysregulation of the transcription factor ER81 and its target genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, direct interactions between CBP and p300 have been reported for SPI1 (117–118) and ETV1 (119, 120).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,465
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., & Rosenfeld, M. G. (1997) · Nature · doi:10.1038/42652 · Cited by 1,283
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M.-J., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,243
Regulation of Transcription by a Protein Methyltransferase
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S.-M., Schurter, B. T., Aswad, D. W., & Stallcup, M. R. (1999) · Science · doi:10.1126/science.284.5423.2174 · Cited by 1,211
p300/CBP proteins: HATs for transcriptional bridges and scaffolds
Chan, H. M., & La Thangue, N. B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2363 · Cited by 1,092
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
The ErbB receptors and their role in cancer progression
Holbro, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00099-x · Cited by 608
RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
Li, H., Gomes, P. J., & Chen, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8479 · Cited by 581
Xu, J., Liao, L., Ning, G., Yoshida-Komiya, H., Deng, C., & O'Malley, B. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120166297 · Cited by 534
Review of the in Vivo Functions of the p160 Steroid Receptor Coactivator Family
Xu, J., & Li, Q. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0116 · Cited by 493
AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor
Font de Mora, J., & Brown, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5041-5047.2000 · Cited by 432
Takeshita, A., Cardona, G. R., Koibuchi, N., Suen, C.-S., & Chin, W. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27629 · Cited by 378
Koh, S. S., Chen, D., Lee, Y.-H., & Stallcup, M. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004228200 · Cited by 358
Specificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Role of HER2 gene overexpression in breast carcinoma
M�nard, S., Tagliabue, E., Campiglio, M., & Pupa, S. M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200002)182:2<150::aid-jcp3>3.0.co;2-e · Cited by 303
Trastuzumab: A Review of its Use in the Treatment of Metastatic Breast Cancer Overexpressing HER2
McKeage, K., & Perry, C. M. (2002) · Drugs · doi:10.2165/00003495-200262010-00008 · Cited by 289
Bautista, S., Valles, H., Walker, R. L., Anzick, S. L., Zeillinger, R., Meltzer, P. S., & Theillet, C. G. (1998) · PubMed · Cited by 264
Suen, C.-S., Berrodin, T. J., Mastroeni, R., Cheskis, B. J., Lyttle, C. R., & Frail, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27645 · Cited by 252
Synergistic, p160 Coactivator-dependent Enhancement of Estrogen Receptor Function by CARM1 and p300
Chen, D., Huang, S.-M., & Stallcup, M. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005459200 · Cited by 238
Na, S.-Y., Lee, S.-K., Han, S.-J., Choi, H.-S., Im, S.-Y., & Lee, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10831 · Cited by 235
Lee, S.-K., Kim, H.-J., Na, S.-Y., Kim, T. S., Choi, H.-S., Im, S.-Y., & Lee, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16651 · Cited by 207
Ghadimi, B. M., Schröck, E., Walker, R. L., Wangsa, D., Jauho, A., Meltzer, P. S., & Ried, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65298-4 · Cited by 197
Ben-Levy, R., Paterson, H. F., Marshall, C. J., & Yarden, Y. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06632.x · Cited by 196
Bouras, T., Southey, M. C., & Venter, D. J. (2001) · PubMed · Cited by 196
Gene regulation by Ets proteins
Janknecht, R. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90014-4 · Cited by 192
Self-citationRegulation of somatic growth by the p160 coactivator p/CIP
Wang, Z., Rose, D. W., Hermanson, O., Liu, F., Herman, T., Wu, W., Szeto, D., Gleiberman, A., Krones, A., Pratt, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260463097 · Cited by 192
Crawford, H. C., Fingleton, B., Gustavson, M. D., Kurpios, N., Wagenaar, R. A., Hassell, J. A., & Matrisian, L. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1370-1383.2001 · Cited by 175
Benz, C. C., O’Hagan, R. C., Richter, B. D., Scott, G. K., Chang, C.-H., Xiong, X., Chew, K., Ljung, B., Edgerton, S. M., Thor, A. D., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201331 · Cited by 155
Chen, S. L., Dowhan, D. H., Hosking, B. M., & Muscat, G. E. O. (2000) · Genes & Development · doi:10.1101/gad.14.10.1209 · Cited by 150
The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis
Shepherd, T. G., Kockeritz, L. K., Szrajber, M. R., Muller, W. J., & Hassell, J. A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00536-x · Cited by 149
Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue
List, H.-J., Reiter, R., Singh, B., Wellstein, A., & Riegel, A. T. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1017910924390 · Cited by 148
The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease.
Janknecht, R. (2002) · PubMed · doi:10.14670/hh-17.657 · Cited by 144
Self-citationE1A directly binds and regulates the P/CAF acetyltransferase
Reid, J. L., Bannister, A. J., Zegerman, P., Martínez‐Balbás, M. A., & Kouzarides, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4469 · Cited by 136
Goueli, B. S., & Janknecht, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.25-35.2004 · Cited by 129
Self-citationAnalysis of the ERK-Stimulated ETS Transcription Factor ER81
Janknecht, R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1550 · Cited by 124
Self-citationJanknecht, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206185 · Cited by 123
Self-citationBelandia, B., & Parker, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000484200 · Cited by 120
HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1
Bosc, D. G., Goueli, B. S., & Janknecht, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204820 · Cited by 120
Self-citationXu, J., & O’Malley, B. W. (2002) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1020016208071 · Cited by 114
Signal integration at the c-fos promoter
Janknecht, R., Cahill, M. A., & Nordheim, A. (1995) · Carcinogenesis · doi:10.1093/carcin/16.3.443 · Cited by 111
Self-citationLiu, Z., Wong, J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231474798 · Cited by 109
Acetylation-Mediated Transcriptional Activation of the ETS Protein ER81 by p300, P/CAF, and HER2/Neu
Goel, A., & Janknecht, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6243-6254.2003 · Cited by 109
Self-citationReiter, R., Wellstein, A., & Riegel, A. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104744200 · Cited by 101
Wu, J., & Janknecht, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205501200 · Cited by 95
Self-citationDowdy, S. C., Mariani, A., & Janknecht, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307202200 · Cited by 95
Self-citationExpression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells
Baert, J.-L., Monté, D., Musgrove, E. A., Albagli, O., Sutherland, R. L., & Launoit, Y. D. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970304)70:5<590::aid-ijc17>3.0.co;2-h · Cited by 94
SAP1a is a nuclear target of signaling cascades involving ERKs.
Janknecht, R., Ernst, W. H., & Nordheim, A. (1995) · PubMed · Cited by 94
Self-citationLee, S., Kim, H., Kim, J. W., & Lee, J. W. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.11.0365 · Cited by 88
Papoutsopoulou, S., & Janknecht, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7300-7310.2000 · Cited by 88
Self-citationCREB-binding Protein/p300 Co-activation of Crystallin Gene Expression
Chen, Q., Dowhan, D. H., Liang, D., Moore, D. D., & Overbeek, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201821200 · Cited by 87
Steroid Receptor Coactivator-3 Is Required for Inhibition of Neointima Formation by Estrogen
Yuan, Y., Liao, L., Tulis, D. A., & Xu, J. (2002) · Circulation · doi:10.1161/01.cir.0000018947.95555.65 · Cited by 85
The PEA3 Group of ETS-related Transcription Factors
de Launoit, Y., Chotteau‐Lelièvre, A., Beaudoin, C., Coutte, L., Netzer, S., Brenner, C., Huvent, I., & Baert, J. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46832-8_13 · Cited by 82
PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
Trimble, M. S., Xin, J.-H., Guy, C. T., Muller, W., & Hassell, J. A. (1993) · PubMed · Cited by 80
Kim, H.-J., Kim, J. H., & Lee, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28564 · Cited by 70
Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81
Bosc, D. G., & Janknecht, R. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10205 · Cited by 57
Self-citationHaro, L. D. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf390 · Cited by 47
Fuchs, B., Inwards, C. Y., & Janknecht, R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00984-0 · Cited by 42
Self-citationJanknecht, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106630200 · Cited by 41
Self-citationLee, K. C., Li, J., Cole, P. A., Wong, J., & Kraus, W. L. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0308 · Cited by 35
Trastuzumab Use in Breast Cancer: Clinical Issues
Horton, J. (2002) · Cancer Control · doi:10.1177/107327480200900607 · Cited by 26
(2000) · doi:10.1002/1097-0215(20000520)89:3<217::aid-ijc2>3.3.co;2-y
Research works printed but not linked: 7
- Bautista, S., Valles, H., Walker, R. L., Anzick, S., Zeillinger, R., Meltzer, P., and Theillet, C. (1998) Clin. Cancer Res. 4, 2925-2929
- Sakakura, C., Hagiwara, A., Yasuoka, R., Fujita, Y., Nakanishi, M., Masuda, K., Kimura, A., Nakamura, Y., Inazawa, J., Abe, T., and Yamagishi, H. (2000) Int. J. Cancer 89, 217-223 · doi:10.1002/1097-0215(20000520)89:3<217::aid-ijc2>3.0.co;2-6
- Trimble, M. S., Xin, J. H., Guy, C. T., Muller, W. J., and Hassell, J. A. (1993) Oncogene 8, 3037-3042
- Janknecht, R., and Nordheim, A. (1993) Biochim. Biophys. Acta 1155, 346 -356
- Janknecht, R., Ernst, W. H., and Nordheim, A. (1995) Oncogene 10, 1209 -1216
- Janknecht, R. (2002) Histol. Histopathol. 17, 657-668
- Bouras, T., Southey, M. C., and Venter, D. J. (2001) Cancer Res. 61, 903-907
Cited by
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
Xu, J., Wu, R.-C., & O'Malley, B. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2695 · Cited by 488
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
Oh, S., Shin, S., & Janknecht, R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.002 · Cited by 249
Self-citationSteroid Receptor Coactivator (SRC) Family: Masters of Systems Biology
York, B., & O'Malley, B. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.193367 · Cited by 230
Metadata
- Authors
- Goel, A., & Janknecht, R.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Janknecht, Ralf
- ORCID
- Janknecht, Ralf
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 15
- Pages
- 14909-14916
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2029169609
- Cited by
- 95
- References
- 65
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 9 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2016: 5 · 2015: 2 · 2014: 6 · 2013: 3 · 2012: 6
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6042 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Fraternal Order of Eagles
- Mayo Foundation for Medical Education and Research
- National Cancer Institute (R01CA085257, CA085257)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- ER81, ETS transcription factors, ACT-R, p160 coactivators, P300, HER2/neu, protein acetylation, transcriptional activation, breast cancer, mammary carcinogenesis, SRC-1, protein-protein interaction
- MeSH terms
- p300-CBP-Associated Factor, Acetyltransferases, Animals, Breast Neoplasms, Carrier Proteins, Cell Line, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Glutathione Transferase, HeLa Cells, Humans, Luciferases, Models, Biological, Nuclear Proteins, Plasmids, Precipitin Tests, Protein Binding, Protein Processing, Post-Translational, Recombinant Fusion Proteins, RNA, Transcription Factors, Transcription, Genetic, RNA-Binding Proteins, Protein Structure, Tertiary, Receptors, Retinoic Acid, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases, Cell Cycle Proteins, Reverse Transcriptase Polymerase Chain Reaction, Nucleocytoplasmic Transport Proteins, p300-CBP Transcription Factors, Histone Acetyltransferases, Nuclear Receptor Coactivator 2, Nuclear Receptor Coactivator 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.